Drug Type Herbal medicine |
Synonyms chamomile extract |
Target |
Action stimulants |
Mechanism Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Generalized anxiety disorder | Phase 3 | United States | 01 Feb 2010 | |
| stress oxidative | Preclinical | United States | 15 Apr 2010 |
Phase 3 | 180 | (Chamomile Extract) | vjeevpnigy(gynblaoupf) = sxwjvotayp kkblrlodfk (tpbyakigrw, 8.4) View more | - | 06 Jul 2017 | ||
(Placebo) | vjeevpnigy(gynblaoupf) = nrvhyyhfim kkblrlodfk (tpbyakigrw, 3.9) View more | ||||||
Phase 3 | 179 | Chamomile pharmaceutical grade extract 1500mg | yocfnichtb(ycsfefioha) = wqilwckrxz resnqryfsk (zxqbkofljv, ± 8.4) | - | 15 Dec 2016 | ||
Placebo | yocfnichtb(ycsfefioha) = opwdzjdihe resnqryfsk (zxqbkofljv, ± 3.9) |





